We are calling for the development of a point-of-care TB test and working to increase access to treatment for drug resistant TB by supporting the introduction of promising new medicines and tackling supply problems of older drugs.
MSF reports on use of the new TB drugs bedaquiline and delamanid
Access to the new TB drugs remains severely limited worldwide, but MSF hopes its experience can inform and encourage wider use, while needed clinical research continues.Read more
Tuberculosis: The Issues
XDR-TB patient successfully completes treatment
Late 2013, Elizabeth started treatment for multidrug-resistant tuberculosis (MDR-TB) at MSF’s Green House Clinic in Nairobi...